OQROGet OQRO Pro
Politician trade (House)

Medtronic (MDT)Rep. Richard Dean Dr McCormick (GA06) disclosed a sale $1K–$15K

Rep. Richard Dean Dr McCormick (GA06) disclosed a sale of Medtronic in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
15 days
Disclosure lag
Traded
Jul 30, 2026
Disclosed
Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  2. Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  3. May 15, 2026CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  4. Jun 3, 2026Company filing · Form 8-K · ResultsReported its results
  5. Jun 8, 2026Insider · 1 personInsiders: 2 sales (~$337K)
  6. Jul 8, 2026InsiderOfficer sold ~$258K of MDT shares in the open market
  7. Jul 9, 2026FDAFDA device clearance: SmartGuard Technology; Predictive Low Glucose Technology
  8. Jul 13, 2026FDARecall: MiniMed 780G Insulin Pump, Model: MMT-1885CLW, MMT-1886CLW
  9. Jul 13, 2026FDARecall: MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
  10. Jul 13, 2026FDARecall: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712;
  11. Jul 14, 2026FDAFDA device clearance: Symmetrix™ L Spinal System
  12. Jul 17, 2026FDAFDA device clearance: Catalyft PL Expandable Interbody System
  13. Jul 27, 2026FDAFDA device clearance: Euphora Rapid Exchange (RX) Balloon Dilatation Catheter
  14. Jul 30, 2026 · this disclosureCongressDisclosed sale of MDT — reported range $1,001 - $15,000

What came next

  1. Jul 31, 2026FDAFDA device clearance: VitalFlow Set with Balance™ Biosurface
  2. Aug 13, 2026FDAFDA device clearance: BIS™ Advance pEEG Module
  3. Aug 14, 2026FDAFDA device clearance: NC Euphora Rapid Exchange Balloon Dilatation Catheter
  4. Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
  5. Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
  6. Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
  7. Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
  8. Sep 4, 2026FDAFDA device clearance: ApexCut ™ Blade with Automated EM Tracking (187BL4012EM);ApexCut ™ Blade with Automated EM Tracking (187BL4040EM);ApexCut ™ Blade with Automated EM Tracking (1…
  9. Sep 15, 2026FDAFDA device clearance: LigaSure™ RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
  10. Sep 16, 2026InsiderOfficer sold ~$139K of MDT shares in the open market
  11. Sep 17, 2026FDAFDA device clearance: Protégé™ EverFlex™ Self-expanding Peripheral Stent System
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Medtronic

For Medtronic, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 50 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by Rep. Richard Dean Dr McCormick (GA06)

The full history of Rep. Richard Dean Dr McCormick (GA06) is on the profile page.

How this filing works

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data